Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia
Hind Alshehri,Adnan Alharbi,Noof Alqethami,Mohammed Alnuhait,Abdullah Alshammari,Abdulmalik Alotaibi
DOI: https://doi.org/10.2147/rmhp.s484223
2024-10-30
Risk Management and Healthcare Policy
Abstract:Hind Alshehri, 1 Adnan Alharbi, 1 Noof Alqethami, 2 Mohammed Alnuhait, 1 Abdullah Alshammari, 1 Abdulmalik S Alotaibi 1 1 Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 2 Clinical Pharmacy Department, Taif Health Cluster, King Faisal Medical Complex, Taif, Saudi Arabia Correspondence: Abdulmalik S Alotaibi, Email Background: Pharmacovigilance (PV) is an essential part of the healthcare system's framework. In Saudi Arabia, pharmacovigilance is still a relatively new concept though it is well established in many countries. Study Aim: In this study, we aim to evaluate knowledge, attitude, and practice regarding pharmacovigilance and barriers to reporting adverse drug reactions (ADRs) among the general public in Saudi Arabia. Methods: This is a cross-sectional study that used a self-administered online questionnaire to assess knowledge, attitude, and practice of PV and ADRs. The study included only the adult population in Saudi Arabia. A scoring system was generated with a scale from 0 to 100, where 80% was set as a cut-off point, as any higher score resembled adequate knowledge, a positive attitude, and good practice. We used the Statistical Package for Social Sciences (SPSS) version 26 for performing the statistical analysis, where para-normal tests were used to associate scores with the socio-demographic characteristics of participants. Results: The study collected 1098 complete responses. The mean age (±SD) of participants was 37.9± 11.2 years. Females comprised 68.9% of the participants. The average knowledge score among participants was 37.8± 18.5, where only 4.3% of respondents had adequate knowledge. The average attitude score was 90.1± 19.2, where 83.4% had a positive attitude. The average practice score was 70.4± 18, and 34.5% of participants had good practice. Conclusion: The study found that the majority of participants had inadequate knowledge, a positive attitude, and poor practice. Individuals holding a master's degree or higher and those working in the healthcare sector had the highest knowledge scores, whereas the group aged 31 to 50 years old, participants from the Al Jawf region, participants who are married with children, holders of a master's degree or higher, and healthcare workers had the best attitude scores. Higher practice scores were seen among married individuals with children and those who work in the healthcare sector. Keywords: pharmacovigilance, adverse drug reactions, knowledge, attitude, practice, Saudi Arabia Pharmacovigilance is widely acknowledged as an important component of the healthcare system. 1 According to the World Health Organization, pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other potential drug-related problems. 1 Maintaining patient safety, which is critical in healthcare systems, is one of the key goals of pharmacovigilance. 2 While pharmacovigilance is a well-established concept in many countries, it is still relatively new in Saudi Arabia. 3 However, it is clear that in many countries, the general public has only a minimal understanding of adverse drug reactions (ADRs) and pharmacovigilance. 4,5 When it comes to the importance of ADRs, they have a significant impact not only on clinical results but also on the economic burden on the healthcare system; the cost of ADRs in the United States (US) might be as high as $30.1 billion per year. 6 According to a study conducted in the United Kingdom (UK), patients are not receiving adequate information regarding ADRs associated with their prescriptions. 7 In Saudi Arabia, ADRs are the most common drug-related problem reported in the emergency department. 8 According to a previous meta-analysis, the rate of ADRs in primary care settings was 8.32%, with nearly 22% of them being preventable. 9 3.5% of hospital admissions in Europe could be attributed to ADRs. 10 It is also typical for people not to notify their physician or pharmacist when they experience an ADR. 11,12 About 15% of patients will stop taking their medications due to ADRs without informing their physician, indicating that they lack the knowledge or awareness to recognize ADRs. As a result, patients should be provided with the skills and knowledge to recognize and report ADRs. 13 This includes information on the drug's adverse reactions as well as what to do if they occur. 13 In Saudi Arabia, more information about the population's actual knowledge, attitude, and practice regarding pharma -Abstract Truncated-
health care sciences & services,health policy & services